Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04526873 · ClinicalTrials.gov registry record · NA
Encouraging Annual Wellness Visits Among ACO Beneficiaries
A NA study of Prevention and Health Promotion, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 41,472
- Enrollment target
- 1
- Study location
NCT04526873: Completed NA study of Prevention and Health Promotion, sponsored by Geisinger Clinic.
NCT04526873 is a NA study of Prevention and Health Promotion that has completed, run by Geisinger Clinic. The registered enrollment target is 41,472 participants, below the 46,222-participant average among 11 other Prevention trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04526873, a NA study of Prevention and Health Promotion, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 41,472 participants
- Enrollment target
- 1
- Study location
Study Summary
Annual Wellness Visits (AWVs) are a type of detailed healthcare checkup to which Medicare beneficiaries are entitled, free of charge, once per year. The purpose of the current study is to assess what content and communication modality results in the most effective messaging campaign to encourage Medicare beneficiaries to schedule their AWVs.
Primary Outcome
Patient scheduled an AWV appointment
Conditions Studied
Interventions
- BEHAVIORAL Phone call
- BEHAVIORAL Telehealth
- BEHAVIORAL Postcard
- BEHAVIORAL Humor/Salience
Study Locations (1)
Pennsylvania
- Geisinger - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41,472 participants |
| Start Date | 2020-09-11 |
| Est. Completion | 2020-12-18 |
| Phase | NA |
What the finished NCT04526873 record still lists
NCT04526873 is an interventional study that assigns participants to a tested intervention. Its 41,472 participants enrollment target places it among the larger protocols in the corpus, below the 46,222-participant average among 11 other Prevention trials with a reported enrollment target (10% lower).
The record links to 4 conditions, with Prevention appearing as the primary indexed condition, and to 4 interventions - of which Phone call is the first listed.
NCT04526873 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04526873 about?
NCT04526873 is a clinical study titled "Encouraging Annual Wellness Visits Among ACO Beneficiaries". Annual Wellness Visits (AWVs) are a type of detailed healthcare checkup to which Medicare beneficiaries are entitled, free of charge, once per year. The purpose of the current study is to assess what content and communication modality results in the most effective messaging campaign to encourage Med...
What is the current status of trial NCT04526873?
This trial is currently completed. It is a NA study. The enrollment target is 41,472 participants. The study started on 2020-09-11. Estimated completion is 2020-12-18.
What conditions does trial NCT04526873 study?
This clinical trial studies the following conditions: Prevention, Health Promotion, Risk Reduction Behavior, Telehealth.
What interventions are being tested in trial NCT04526873?
The interventions under investigation include: Phone call (BEHAVIORAL), Telehealth (BEHAVIORAL), Postcard (BEHAVIORAL), Humor/Salience (BEHAVIORAL).
Who is sponsoring clinical trial NCT04526873?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04526873 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04526873's enrollment target sits among peer trials
41,472 2nd of 11 the highest of 11 other Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).
RECRUITING · NA
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Optimizing PrEP Uptake and Adherence Among Male Sex Workers
RECRUITING · NA
-
Enhancing Oral Cancer Awareness
RECRUITING · NA
-
Virtual Reality Experience for Stress Reduction in Cardiology Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI